凡拓數創(301313.SZ):部分募投項目結項
格隆匯7月11日丨凡拓數創(301313.SZ)公佈,公司於2025年7月10日召開了第四屆董事會第十四次會議、第四屆監事會第十四次會議,審議通過了《關於募投項目結項並將節餘募集資金及超募資金節餘利息永久補充流動資金的議案》,鑑於公司首次公開發行股票募集資金投資項目中的“總部數字創意製作基地項目”及“營銷網絡升級及數字展示中心建設項目”已於日前達到預定可使用狀態,公司已於近期將上述募投項目結項。
公司擬將上述募投項目的節餘募集資金及超募資金的節餘利息共計2352.34萬元(實際金額以資金轉出當日募集資金專户餘額為準)用於永久補充流動資金,用於公司日常經營活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.